Amgen

The drug is already approved for three indications, including to treat patients with moderate-to-severe plaque psoriasis and…

Otezla resulted in clinically and statistically significant improvements in measures of genital psoriasis at week 16 compared with…

Through the latest deal, Amgen will get access to Five Prime’s lead drug candidate, bemarituzumab, which is ready to enter a…

Together, the companies hope to be able to produce many millions of doses even next year

I-SPY COVID will evaluate the impact of cenicriviroc, otezla, and firazyr on inflammatory response in severely ill, hospitalised…

The approval granted through a business review letter from the Justice Department's antitrust division, however, has not allowed…

Cipla's cinacalcet hydrochloride tablets, in the strengths of 30mg, 60mg and 90mg, are generic versions of Sensipar, a branded…

Amgen and Allergan’s biosimilar candidate to Roche’s Rituxan (rituximab) shows the greatest potential of these drugs Out of all…

The industry also reported 85 venture capital (VC) deals worth US$1.7 billion in October 2019, compared to the last 12-month…

Amgen’s proposed acquisition of Otezla from Celgene for $13.4 billion provides 71 per cent to deal value